Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study

Código QR

Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study

Introduction: Chronic inflammatory demyelinating polyneuropathy (CIDP) is a complex autoimmune disease caused by dysregulated response to not fully recognized antigens. Some association between CIDP and inflammatory bowel disease (IBD) has been reported, but the exact pathophysiological links of the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Magdalena Koszewicz, Agata Mulak, Edyta Dziadkowiak, Sławomir Budrewicz
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	chronic inflammatory demyelinating polyneuropathy intestinal inflammation fecal calprotectin gut immune system gut microbiota Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/bb9ea6807f5b4880a217c34bde1785f5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Fecal calprotectin and microbiota of the gut
por: V. G. Gorokhova, et al.
Publicado: (2016)

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
por: Rajabally YA, et al.
Publicado: (2020)

Fecal Microbiota Transplantation Beneficially Regulates Intestinal Mucosal Autophagy and Alleviates Gut Barrier Injury
por: Saisai Cheng, et al.
Publicado: (2018)

Length-dependent changes of lower limb muscle morphology in Chronic Inflammatory Demyelinating Polyneuropathy assessed with magnetic resonance imaging
por: Jacob Fanous, et al.
Publicado: (2021)

Acute Neuromuscular Respiratory Weakness Due to Acute Inflammatory Demyelinating Polyneuropathy (AIDP): A Simulation Scenario for Neurology Providers
por: Roshni Abee Patel, et al.
Publicado: (2019)

Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Ning Li, et al.
Publicado: (2021)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao Y, et al.
Publicado: (2021)

Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Ning Li, et al.
Publicado: (2021)

Separation of Donor and Recipient Microbial Diversity Allows Determination of Taxonomic and Functional Features of Gut Microbiota Restructuring following Fecal Transplantation
por: Evgenii I. Olekhnovich, et al.
Publicado: (2021)

ELECTRONEUROMYOGRAPHY EXAMINATION OF DIABETIC POLYNEUROPATHY PATIENTS
por: Siti Nurlaela, et al.
Publicado: (2019)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Gianluca Ianiro, et al.
Publicado: (2021)

Prospects for the use of fecal microbiota transplantation in obese patients with Type 2 Diabetes Mellitus for weight loss and improvement of insulin sensitivity
por: E. V. Pokrovskaya, et al.
Publicado: (2021)

Fecal Microbiome Transplantation from Children with Autism Spectrum Disorder Modulates Tryptophan and Serotonergic Synapse Metabolism and Induces Altered Behaviors in Germ-Free Mice
por: Lu Xiao, et al.
Publicado: (2021)

The Induction of Oxalate Metabolism <italic toggle="yes">In Vivo</italic> Is More Effective with Functional Microbial Communities than with Functional Microbial Species
por: Aaron W. Miller, et al.
Publicado: (2017)

Increasing the Hindgut Carbohydrate/Protein Ratio by Cecal Infusion of Corn Starch or Casein Hydrolysate Drives Gut Microbiota-Related Bile Acid Metabolism To Stimulate Colonic Barrier Function
por: Yu Pi, et al.
Publicado: (2020)

Effects of Antibiotic Pretreatment of an Ulcerative Colitis-Derived Fecal Microbial Community on the Integration of Therapeutic Bacteria <italic toggle="yes">In Vitro</italic>
por: Kaitlyn Oliphant, et al.
Publicado: (2020)

A Subset of Roux-en-Y Gastric Bypass Bacterial Consortium Colonizes the Gut of Nonsurgical Rats without Inducing Host-Microbe Metabolic Changes
por: Zhigang Liu, et al.
Publicado: (2020)

Distinct Fecal and Plasma Metabolites in Children with Autism Spectrum Disorders and Their Modulation after Microbiota Transfer Therapy
por: Dae-Wook Kang, et al.
Publicado: (2020)

Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives
por: Alba Rocco, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Gestating Sows and Neonatal Offspring Alters Lifetime Intestinal Microbiota and Growth in Offspring
por: Ursula M. McCormack, et al.
Publicado: (2018)

Effects of Partially Hydrolyzed Guar Gum Supplementation on the Fecal Microbiotas of Piglets
por: Ryo Inoue, et al.
Publicado: (2021)

Microbiota‐derived extracellular vesicles in interkingdom communication in the gut
por: Natalia Díaz‐Garrido, et al.
Publicado: (2021)

Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
por: Zhe Zhao, et al.
Publicado: (2021)

Altered Fecal Microbiota Signatures in Patients With Anxiety and Depression in the Gastrointestinal Cancer Screening: A Case-Control Study
por: Juan Zhu, et al.
Publicado: (2021)

Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
por: Velikova Tsvetelina, et al.
Publicado: (2018)

Effects of Probiotics on Human Health and Disease: A Review
por: Amiri A., et al.
Publicado: (2021)

Preterm infant meconium microbiota transplant induces growth failure, inflammatory activation, and metabolic disturbances in germ-free mice
por: Henni Hiltunen, et al.
Publicado: (2021)

Research progress of gut microbiota and frailty syndrome
por: Wang Xiao, et al.
Publicado: (2021)

Extracellular vesicles derived from gut microbiota in inflammatory bowel disease and colorectal cancer
por: Giusi Alberti, et al.
Publicado: (2021)

Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease
por: Manasvini Markandey, et al.
Publicado: (2021)

Gut microbiota disorder caused by diterpenoids extracted from Euphorbia pekinensis aggravates intestinal mucosal damage
por: Kuilong Wang, et al.
Publicado: (2021)

L-arginine as a novel target for clinical intervention in inflammatory bowel disease
por: Björn Nüse, et al.
Publicado: (2021)

Altered Fecal Microbiota Correlated With Systemic Inflammation in Male Subjects With Methamphetamine Use Disorder
por: Di Deng, et al.
Publicado: (2021)

Guillain–Barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report
por: Javadi Parvaneh V, et al.
Publicado: (2019)

Maternal Emulsifier P80 Intake Induces Gut Dysbiosis in Offspring and Increases Their Susceptibility to Colitis in Adulthood
por: Ge Jin, et al.
Publicado: (2021)

Probiotics in Intestinal Mucosal Healing: A New Therapy or an Old Friend?
por: Eirini Filidou, et al.
Publicado: (2021)

Involvement of Gut Microbiota in the Development of Psoriasis Vulgaris
por: Chaonan Sun, et al.
Publicado: (2021)

Reconstruction of intestinal microecology of Type 2 diabetes by fecal microbiota transplantation: Why and how
por: Kaijian Hou, et al.
Publicado: (2021)

Improvement in Clinical Symptoms and Fecal Microbiome After Fecal Microbiota Transplantation in a Dog with Inflammatory Bowel Disease
por: Niina A, et al.
Publicado: (2019)

Wood-Derived Dietary Fibers Promote Beneficial Human Gut Microbiota
por: Sabina Leanti La Rosa, et al.
Publicado: (2019)